UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases.
about
Autoimmune diseases - connecting risk alleles with molecular traits of the immune system.Mechanism and disease association of E2-conjugating enzymes: lessons from UBE2T and UBE2L3Advances in lupus geneticsNetwork biology concepts in complex disease comorbiditiesGeneration and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitorsMapping eQTLs with RNA-seq reveals novel susceptibility genes, non-coding RNAs and alternative-splicing events in systemic lupus erythematosusGenetics of Lupus Nephritis: Clinical Implications.Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus.Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.The Sharpin interactome reveals a role for Sharpin in lamellipodium formation via the Arp2/3 complex.The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus.Linear ubiquitin chains: enzymes, mechanisms and biologyIntracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity.The Atypical Ubiquitin E2 Conjugase UBE2L3 Is an Indirect Caspase-1 Target and Controls IL-1β Secretion by Inflammasomes.A cis-eQTL genetic variant of the cancer-testis gene CCDC116 is associated with risk of multiple cancers.Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups.Profiling RNA-Seq at multiple resolutions markedly increases the number of causal eQTLs in autoimmune disease.Ubiquitin conjugating enzyme E2 L3 promoted tumor growth of NSCLC through accelerating p27kip1 ubiquitination and degradation.The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases.Abnormal B-cell development in Systemic Lupus Erythematosus: what the genetics tell us.Updates in Lupus Genetics.Internally tagged ubiquitin: a tool to identify linear polyubiquitin-modified proteins by mass spectrometry.Determinants of E2-ubiquitin conjugate recognition by RBR E3 ligases.Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.Integrative Analysis Identifies Genetic Variants Associated With Autoimmune Diseases Affecting Putative MicroRNA Binding Sites.Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studiesUbiquitin-Proteasome System: Promising Therapeutic Targets in Autoimmune and Neurodegenerative Diseases
P2860
Q26767040-FCFCC495-15E2-4EFB-BE3A-35F79DE97E6CQ28067393-E251AC4F-F3F9-4504-BC70-8B1F586171FCQ28088718-8D33B34C-9E2C-44F7-AACD-5DCE3C1FF4B7Q29091067-4B99B380-847A-44A6-9727-E1DD576CC0F8Q29247925-563F9005-E6FA-4233-AD44-97A5C050EA4BQ33614670-CFE7007C-2389-430F-A5DC-BB07A29D69B5Q36300008-042D1C6F-575B-412C-A872-339F69566675Q36343939-F64EB5CB-3C88-45F2-80BC-DD04102B7997Q38396871-688D72A6-8A48-442C-A915-267DA9308070Q38642362-AEDBBF2E-F31F-4DD3-A1A7-7F89831282F9Q38784456-A6E3A9B7-D21C-43F1-9F94-3DA1ABCF224FQ39265294-A0980FE2-997B-40C1-AF1B-B98BADFF27ABQ39272758-E0FF4879-1F9F-4547-9E7A-C78E171F75CEQ40070954-F4648BE1-B7CD-42FD-B0DF-7FC6AAAA9E0AQ40144423-6E74ADF0-E748-42B2-81A0-23277B286B18Q42098903-5D207B43-4BFA-453A-B901-C15F3A61A24BQ42698342-E189661C-1B62-40A5-BC23-BB1083B42023Q46792450-F53F4BE8-2F08-4D64-8FA1-10B2103DFEE4Q47134266-C8B16604-3F44-4424-8841-63CAFF9E9465Q47365066-4AB54595-633B-412C-B994-1C9D28E9E8D3Q47852851-B6F22391-BCF7-4132-B840-EC90AC3963BCQ48103457-9815E5B2-A03E-4F5B-905D-565508CB0F2EQ48293242-F73DE718-FFF2-4BD8-9EF4-D5732E24F9AAQ48522341-6A6027DA-6ABC-451A-A5B8-BDFF960FDDC2Q55172908-2F352B20-8AD4-4056-BFA4-A329D36D00B4Q56998606-B436805B-774B-4460-96E1-0DF510A014C9Q58051874-914A2C50-60B2-422D-BF32-A8B80C7894EB
P2860
UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
UBE2L3 polymorphism amplifies ...... multiple autoimmune diseases.
@ast
UBE2L3 polymorphism amplifies ...... multiple autoimmune diseases.
@en
type
label
UBE2L3 polymorphism amplifies ...... multiple autoimmune diseases.
@ast
UBE2L3 polymorphism amplifies ...... multiple autoimmune diseases.
@en
prefLabel
UBE2L3 polymorphism amplifies ...... multiple autoimmune diseases.
@ast
UBE2L3 polymorphism amplifies ...... multiple autoimmune diseases.
@en
P2093
P2860
P50
P1476
UBE2L3 polymorphism amplifies ...... o multiple autoimmune diseases
@en
P2093
Henning Walczak
Patrick A Gordon
Simon Vyse
Timothy D Spector
Timothy J Vyse
P2860
P304
P356
10.1016/J.AJHG.2014.12.024
P407
P577
2015-01-29T00:00:00Z